Detection and differentiation of Clostridium botulinum type A strains using a focused DNA microarray

Brian H Raphael1, Lavin A Joseph, Loretta M McCroskey

  • 1Enteric Diseases Laboratory Branch, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. elx9@cdc.gov

Summary

A new microarray accurately differentiates Clostridium botulinum type A strains by analyzing variable genomic regions and detecting neurotoxin genes. This method rapidly assesses strain relatedness from different sources during outbreaks.

Related Concept Videos